Physician

Daniel Levy, MD

According to 2025 Medicare claims, Daniel Levy, MD (NPI: 1306067814) practices dermatology in the Tacoma-Lakewood, WA market, with the plurality of this provider's patient population coming from Pierce, WA. This provider's primary affiliated billing organization is LARK DERMATOLOGY (NPI: 1982256970; TIN: 834372348) and primary practice location at 98391-9998.

Levy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 31 traditional Medicare patients, billed 10,002 HCPCS/CPT codes, and received $13,867,184 in Medicare payments. The top billing code was 77600 (Use of externally generated heat to increase temperature of cancer cell, heating to depths 4.0 cm or less). Part D data shows 89 prescription claims across 26 beneficiaries totaling $1,700 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). 2022 DME data shows 11 claims. Open Payments data shows 94 records totaling $52,896. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $4,932 to $1,700. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$6.9M$14M2022 Medicare payment: $2,270,857 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,079,250 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $13,867,184 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022904,739$2,270,857
2023454,184$2,079,250
20243110,002$13,867,184

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.2K$10K2015 Drug cost: $4,932 (USD; Tot_Drug_Cst)2016 Drug cost: $10,437 (USD; Tot_Drug_Cst)2017 Drug cost: $7,061 (USD; Tot_Drug_Cst)2018 Drug cost: $126 (USD; Tot_Drug_Cst)2019 Drug cost: $1,939 (USD; Tot_Drug_Cst)2020 Drug cost: $692 (USD; Tot_Drug_Cst)2022 Drug cost: $2,805 (USD; Tot_Drug_Cst)2023 Drug cost: $2,691 (USD; Tot_Drug_Cst)2024 Drug cost: $1,700 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151584$4,932
201613102$10,437
2017N/R29$7,061
2018N/R12$126
20191439$1,939
2020N/R17$692
2021N/RN/RN/R
20222956$2,805
20233091$2,691
20242689$1,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$115$2302022 Medicare payment: $230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R11$230
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77600Use of externally generated heat to increase temperature of cancer cell, heating to depths 4.0 cm or less27241$441
77280Obtaining data needed to develop the optimal radiation treatment, 1 treatment area27260$218
0394THigh dose rate electronic brachytherapy, external27275$131

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Doxycycline HyclateDoxycycline Hyclate11330$521
LevofloxacinLevofloxacin12360$497
MinoxidilMinoxidil15690$160
Ondansetron OdtOndansetron12116$108

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.94$52,896ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Levy, MD?

Tedicare shows public-source Medicare data for Daniel Levy, MD (NPI 1306067814), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Levy, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Levy, MD?

Daniel Levy, MD is linked to LARK DERMATOLOGY (billing NPI 1982256970) in the available physician profile data.

Does Daniel Levy, MD have Open Payments data?

Daniel Levy, MD has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.